// App-Quantinova.ai

244 : Targeted therapy using intradermal injection of etanercept for remission induction in discoid lupus erythematosus (TARGET-DLE): results from a proof-of-concept phase II trial

Researchers

Presenter

  • Md Yuzaiful

Principal Investigators

  • Md Yusof

  • Miriam Wittmann

  • Catherine Fernandez

  • Duncan Wilson

  • Sara Edward

  • Giuseppina Abignano

  • Adewonuola Alase

  • Linda Sharples

  • Philip Laws

  • Mark Goodfield

  • Edward M Vital

  • Paul Emery

Medical Centers

  • Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, United Kingdom

  • Department of Histopathology, Leeds Teaching Hospitals NHS Trust, Leeds, UNITED KINGDOM

  • Department of Medical Statistics, London School of Hygiene and Tropical Medicine, London, United Kingdom

  • Department of Clinical Haematology, Leeds Teaching Hospitals NHS Trust, Leeds,

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Lupus

Biomarkers

  • N/A

Drug/Treatment

  • Etanercept

  • CHS-0214

Outcome

  • N/A

Study Design

  • Open Label

  • Single Arm

  • Prospective

Phase

  • II

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved